OptimizeRx (NASDAQ:OPRX) and Binovi Technologies (OTCMKTS:BNVIF) Head-To-Head Contrast

OptimizeRx (NASDAQ:OPRX) and Binovi Technologies (OTCMKTS:BNVIF) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, profitability and dividends.

Profitability

This table compares OptimizeRx and Binovi Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Binovi Technologies	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for OptimizeRx and Binovi Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Binovi Technologies	0	0	0	0	0.00

OptimizeRx presently has a consensus price target of $11.43, indicating a potential upside of 43.58%. Given OptimizeRx’s stronger consensus rating and higher probable upside, research analysts clearly believe OptimizeRx is more favorable than Binovi Technologies.

Earnings and Valuation

This table compares OptimizeRx and Binovi Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$98.65 million	1.52	$5.13 million	$0.23	34.61
Binovi Technologies	N/A	N/A	N/A	N/A	N/A

OptimizeRx has higher revenue and earnings than Binovi Technologies.

Insider & Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

OptimizeRx beats Binovi Technologies on 9 of the 9 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Binovi Technologies

Binovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.